Back

LLY Stock

Live symbol workspace

LLY market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $935.58
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for LLY...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$888.80
Resistance
$982.36

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Technical Context

Current price
$935.58
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

32%
▲ 1.8 pts vs previous week
Avg confidence across 34 calls in the last 7 days

What sources say

Bullish 1 article
Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade
Bearish 1 article
Eli Lilly and Company (LLY) Fell on Regulatory And Pricing Policy Challenges

Insider Trading

Insider Role Date Type Value
LILLY ENDOWMENT, INC. Shareholder Jul 07 '26 Proposed Sale 372018600.0
LILLY ENDOWMENT, INC. Shareholder Jun 26 '26 Proposed Sale 343945450.0
Yuffa Ilya EVP&Pres, LLY … Jun 10 '26 Sale 2876925.0
Yuffa Ilya Officer Jun 10 '26 Proposed Sale 2876925.0
LILLY ENDOWMENT, INC. Shareholder May 28 '26 Proposed Sale 335705200.0
LILLY ENDOWMENT, INC. Shareholder May 22 '26 Proposed Sale 312495000.0
LILLY ENDOWMENT, INC. Shareholder May 20 '26 Proposed Sale 311530050.0
LILLY ENDOWMENT INC Former 10% … May 06 '26 Sale 15754537.0
LILLY ENDOWMENT, INC. Shareholder May 06 '26 Proposed Sale 296661000.0
Zakrowski Donald A SVP, Finance, … Feb 16 '26 Option Exercise 0.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

LLY News Intelligence (20 articles)

AI-curated news influencing LLY price, sentiment, and trend

Explore All LLY News with AI Analysis
Stocks
3 months, 3 weeks ago

An end to the Iran conflict should rally stocks — but only briefly

Private-credit cracks, high stock valuations and shaky IPO prospects will curb investors’ enthusiasm.

Impact on LLY: Neutral market sentiment indicated
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)
View full analysis →
Economy
3 months, 3 weeks ago

Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts

Eli Lilly & Co. shares dip after HSBC turned bearish on the stock, for the second time in a year, …

Impact on LLY: The bearish call from HSBC may lead to a short-term decline in …
Eli Lilly & Co. shares experience a decline after HSBC turns bearish on the stock, … High (70%)
View full analysis →
Economy
4 months ago

Should You Buy Eli Lilly Stock Now or Wait for More of a Pullback?

Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.

Impact on LLY: Market impact analysis based on bearish sentiment with 80% confidence.
Eli Lilly's stock is considered overpriced, despite a decline this year, making it a potentially … High (80%)
View full analysis →
Economy
4 months, 2 weeks ago

Is Eli Lilly Stock Underperforming the S&P 500?

Eli Lilly has recently trailed the S&P 500 Index, though analysts remain confident in its longer-term trajectory.

Impact on LLY: Market impact analysis based on neutral sentiment with 70% confidence.
Eli Lilly stock has underperformed the S&P 500 Index, but analysts remain optimistic about its … High (70%)
View full analysis →
Economy
5 months ago

Eli Lilly Stock Rises. It’s Acquiring This Cell Therapy Company for $2.4 Billion.

Eli Lilly shares rose after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 …

Impact on LLY: Market impact analysis based on bullish sentiment with 90% confidence.
Eli Lilly's stock rose after the company announced a $2.4 billion acquisition of Orna Therapeutics, … High (90%)
View full analysis →
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis